Neoadjuvant chemotherapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) or cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in 69 cases of locally advanced (stage IIIb) breast cancer-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) or cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in 69 cases of locally advanced (stage IIIb) breast cancer

Published:1991-11 Issue:6 Volume:21 Page:637-642
ISSN:0047-1909
Container-title:The Japanese Journal of Surgery
language:en
Short-container-title:The Japanese Journal of Surgery

Author:

Gupta Pankaj,Bilani Loveleen,Rath Gaur K.,Misra Anoop,Mishra Mahesh C.,Shurla Nutan K.,Kriplani Ajay,Kapur Brij M. L.

Publisher

Springer Science and Business Media LLC

Subject

Surgery,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/BF02471048.pdf

Reference9 articles.

1. Davila E, Vogel CL. Management of locally advanced breast cancer (stage III): a review. Int Adv Surg Oncol 1984; 7: 297–327.

2. Hery M, Namer M, Moro M, Boublil JL, Lalanne CM. Conservative treatment (chemotherapy/radiotherapy) of locally advanced breast cancer. Cancer 1986; 57: 1744–1749.

3. Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D, Hug V, Holmes FA, Romsdahl MM, Fraschini G, McBride CM, Martin RG, Montague E. Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 1988; 62: 2507–2516.

4. Delena M, Zucali R, Viganotti G, Valagussa P, Bonnadonna G. Combined chemotherapy/radiotherapy approach in locally advanced (T 3b, T4) breast cancer. Cancer Chemother Pharmacol 1978; 1: 53–59.

5. Rubens RD, Sexton S, Tong D, Winter PS, Knight RK, Hayward JL. Combined chemotherapy and radiotherapy for locally advanced breast cancer. Eur J Cancer 1980; 16: 351–356.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Locally Advanced Breast Cancer;Breast Cancer;2022

2. Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience;Breast Cancer Research and Treatment;2013-12-11

3. Résultats à 10 ans d'un essai randomisé de chimiothérapie néo-adjuvante dans les cancers du sein de plus de 3 cm;Chirurgie;1998-06